Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹76.25.
30 Oct: open ₹77.77, high ₹77.77, low ₹76.60
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹277 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,475
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 11 of 30.
Apr 2022
11 Apr · Legal
Clarification sought from Lyka Labs Ltd
Feb 2022
25 Feb · Post Offer Public announcement
25 Feb · Updates on Open Offer
Jan 2022
25 Jan · Updates on Open Offer
25 Jan · Open Offer
20 Jan · Results
20 Jan · Board meeting
20 Jan · Updates on Open Offer
19 Jan · Updates on Open Offer
19 Jan · Letter of Offer
14 Jan · Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
Shareholding for the Period Ended December 31, 202113 Jan · Board meeting
12 Jan · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Statement Of Investor Complaints For The Quarter Ended December 2021
Dec 2021
20 Dec · Updates
8 Dec · Draft Letter of Offer
1 Dec · Public Announcement-Open Offer
1 Dec · Updates on Open Offer
Nov 2021
24 Nov · Updates
24 Nov · Public Announcement To Equity Shareholders Of Lyka Labs Limited
24 Nov · Public Announcement-Open Offer
1 Nov · Legal
Exchange has sought clarification from Lyka Labs Limited with respect to announcement dated 29-Oct-2021, regarding merger of Lyka Exports Limited with Lyka Labs Limited. On basis of above the Company is required to clarify following: 1. Brief details of change in shareholding pattern (if any) of listed entity;2. Name of the entity (ies) forming part of the amalgamation/merger, details in brief such as, size, turnover etc.;3. Whether the transaction would fall within related party transactions? If yes, whether the same is done at arm's length;4. Area of business of the entity (ies);5. Rationale for amalgamation/ merger;6. In case of cash consideration amount or otherwise share entitlement/exchange ratio.The response of the Company is awaited.
Oct 2021
29 Oct · Updates
29 Oct · Results